C-Myc-dependent transcriptional regulation of cell cycle and nucleosomal histones during oligodendrocyte differentiation

Neuroscience

Volumn 276, Issue , 2014, Pages 72-86

  Magri, L ^a   Gacias, M ^a   Wu, M ^a   Swiss, V A ^a,b   Janssen, W G ^a   Casaccia, P ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b JANSSEN RESEARCH AND DEVELOPMENT   (United States)

Author keywords

CNS; Development; Epigenetic; Glioma; Histone variant; Myelin

Indexed keywords

CYCLIN DEPENDENT KINASE 1; HISTONE; HISTONE H2AZ; MYC PROTEIN; TRANSCRIPTION FACTOR; NUCLEOSOME;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BIOINFORMATICS; CELL CYCLE REGULATION; CELL PROLIFERATION; CHROMATIN IMMUNOPRECIPITATION; CHROMATIN STRUCTURE; CHROMOSOME STRUCTURE; GENE SILENCING; GENETIC TRANSCRIPTION; HISTONE ACETYLATION; HISTONE METHYLATION; MOLECULAR MECHANICS; MOUSE; NERVE CELL DIFFERENTIATION; NONHUMAN; NUCLEOSOME; OLIGODENDROCYTE PRECURSOR CELL; OLIGODENDROGLIA; PHENOTYPE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BINDING; PROTEIN EXPRESSION; RAT; TRANSCRIPTION REGULATION; ANIMAL; C57BL MOUSE; CELL CULTURE; CELL CYCLE; CELL DIFFERENTIATION; CYTOLOGY; GENETICS; METABOLISM; STEM CELL; TRANSCRIPTION INITIATION;

ANIMALS; CELL CYCLE; CELL DIFFERENTIATION; CELL PROLIFERATION; CELLS, CULTURED; HISTONES; MICE; MICE, INBRED C57BL; NUCLEOSOMES; OLIGODENDROGLIA; PROTO-ONCOGENE PROTEINS C-MYC; STEM CELLS; TRANSCRIPTIONAL ACTIVATION;

EID: 84906794833     PISSN: 03064522     EISSN: 18737544     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2014.01.051     Document Type: Article

References (58)

1. Albert I., Mavrich T.N., Tomsho L.P., Qi J., Zanton S.J., Schuster S.C., Pugh B.F. Translational and rotational settings of H2A.Z nucleosomes across the Saccharomyces cerevisiae genome. Nature 2007, 446:572-576.
2. Amati B., Frank S.R., Donjerkovic D., Taubert S. Function of the c-Myc oncoprotein in chromatin remodeling and transcription. Biochim Biophys Acta 2001, 1471:M135-M145.
3. Barnett S.C., Crouch D.H. The effect of oncogenes on the growth and differentiation of oligodendrocyte type 2 astrocyte progenitor cells. Cell Growth Differ 1995, 6:69-80.
4. Barnett S.C., Robertson L., Graham D., Allan D., Rampling R. Oligodendrocyte-type-2 astrocyte (O-2A) progenitor cells transformed with c-myc and H-ras form high-grade glioma after stereotactic injection into the rat brain. Carcinogenesis 1998, 19:1529-1537.
5. Blackwell T.K., Kretzner L., Blackwood E.M., Eisenman R.N., Weintraub H. Sequence-specific DNA binding by the c-Myc protein. Science 1990, 250:1149-1151.
6. Cahoy J.D., Emery B., Kaushal A., Foo L.C., Zamanian J.L., Christopherson K.S., Xing Y., Lubischer J.L., Krieg P.A., Krupenko S.A., et al. A transcriptome database for astrocytes, neurons, and oligodendrocytes: a new resource for understanding brain development and function. J Neurosci 2008, 28:264-278.
7. Cetinkaya C., Hultquist A., Su Y., Wu S., Bahram F., Pahlman S., Guzhova I., Larsson L.G. Combined IFN-gamma and retinoic acid treatment targets the N-Myc/Max/Mad1 network resulting in repression of N-Myc target genes in MYCN-amplified neuroblastoma cells. Mol Cancer Ther 2007, 6:2634-2641.
8. Creyghton M.P., Markoulaki S., Levine S.S., Hanna J., Lodato M.A., Sha K., Young R.A., Jaenisch R., Boyer L.A. H2AZ is enriched at polycomb complex target genes in ES cells and is necessary for lineage commitment. Cell 2008, 135:649-661.
9. Dang C.V. C-Myc target genes involved in cell growth, apoptosis, and metabolism. Mol Cell Biol 1999, 19:1-11.
10. Dang C.V., Le A., Gao P. MYC-induced cancer cell energy metabolism and therapeutic opportunities. Clin Cancer Res 2009, 15:6479-6483.
11. Dennis G., Sherman B.T., Hosack D.A., Yang J., Gao W., Lane H.C., Lempicki R.A. DAVID: database for annotation, visualization, and integrated discovery. Genome Biol 2003, 4:3.
12. Draker R., Cheung P. Transcriptional and epigenetic functions of histone variant H2A.Z. Biochemistry and cell biology = Biochim. Biol. Cell. 2009, 87:19-25.
13. Dugas J.C., Tai Y.C., Speed T.P., Ngai J., Barres B.A. Functional genomic analysis of oligodendrocyte differentiation. J Neurosci 2006, 26:10967-10983.
14. Dyson N. The regulation of E2F by pRB-family proteins. Genes Dev 1998, 12:2245-2262.
15. Frank S.R., Parisi T., Taubert S., Fernandez P., Fuchs M., Chan H.M., Livingston D.M., Amati B. MYC recruits the TIP60 histone acetyltransferase complex to chromatin. EMBO Rep 2003, 4:575-580.
16. Frank S.R., Schroeder M., Fernandez P., Taubert S., Amati B. Binding of c-Myc to chromatin mediates mitogen-induced acetylation of histone H4 and gene activation. Genes Dev 2001, 15:2069-2082.
17. Guccione E., Martinato F., Finocchiaro G., Luzi L., Tizzoni L., Dall' Olio V., Zardo G., Nervi C., Bernard L., Amati B. Myc-binding-site recognition in the human genome is determined by chromatin context. Nat Cell Biol 2006, 8:764-770.
18. Hanson H.H., Reilly J.E., Lee R., Janssen W.G., Phillips G.R. Streamlined embedding of cell monolayers on gridded glass-bottom imaging dishes for correlative light and electron microscopy. Microsc Microanal 2010, 16:747-754.
19. He Y., Dupree J., Wang J., Sandoval J., Li J., Liu H., Shi Y., Nave K.A., Casaccia-Bonnefil P. The transcription factor Yin Yang 1 is essential for oligodendrocyte progenitor differentiation. Neuron 2007, 55:217-230.
20. Hirvonen H.E., Salonen R., Sandberg M.M., Vuorio E., Vastrik I., Kotilainen E., Kalimo H. Differential expression of myc, max and RB1 genes in human gliomas and glioma cell lines. Br J Cancer 1994, 69:16-25.
21. Huang da W., Sherman B.T., Lempicki R.A. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc 2009, 4:44-57.
22. Jensen N.A., Celis J.E. Proteomic changes associated with degeneration of myelin-forming cells in the central nervous system of c-myc transgenic mice. Electrophoresis 1998, 19:2014-2020.
23. Jung M., Kramer E., Grzenkowski M., Tang K., Blakemore W., Aguzzi A., Khazaie K., Chlichlia K., von Blankenfeld G., Kettenmann H., et al. Lines of murine oligodendroglial precursor cells immortalized by an activated neu tyrosine kinase show distinct degrees of interaction with axons in vitro and in vivo. Eur J Neurosci 1995, 7:1245-1265.
24. Knoepfler P.S., Cheng P.F., Eisenman R.N. N-myc is essential during neurogenesis for the rapid expansion of progenitor cell populations and the inhibition of neuronal differentiation. Genes Dev 2002, 16:2699-2712.
25. Knoepfler P.S., Zhang X.Y., Cheng P.F., Gafken P.R., McMahon S.B., Eisenman R.N. Myc influences global chromatin structure. EMBO J 2006, 25:2723-2734.
26. La Rocca S.A., Crouch D.H., Gillespie D.A. C-Myc inhibits myogenic differentiation and myoD expression by a mechanism which can be dissociated from cell transformation. Oncogene 1994, 9:3499-3508.
27. Lachmann A., Xu H., Krishnan J., Berger S.I., Mazloom A.R., Ma'ayan A. ChEA: transcription factor regulation inferred from integrating genome-wide ChIP-X experiments. Bioinformatics 2010, 26:2438-2444.
28. Lei L., Sonabend A.M., Guarnieri P., Soderquist C., Ludwig T., Rosenfeld S., Bruce J.N., Canoll P. Glioblastoma models reveal the connection between adult glial progenitors and the proneural phenotype. PLoS One 2011, 6:e20041.
29. Liu J., Casaccia P. Epigenetic regulation of oligodendrocyte identity. Trends Neurosci 2010, 33:193-201.
30. Liu J., Sandoval J., Doh S.T., Cai L., Lopez-Rodas G., Casaccia P. Epigenetic modifiers are necessary but not sufficient for reprogramming non-myelinating cells into myelin gene-expressing cells. PLoS One 2010, 5:e13023.
31. Liu X., Tesfai J., Evrard Y.A., Dent S.Y., Martinez E. C-Myc transformation domain recruits the human STAGA complex and requires TRRAP and GCN5 acetylase activity for transcription activation. J Biol Chem 2003, 278:20405-20412.
32. Lyssiotis C.A., Walker J., Wu C., Kondo T., Schultz P.G., Wu X. Inhibition of histone deacetylase activity induces developmental plasticity in oligodendrocyte precursor cells. Proc Natl Acad Sci U S A 2007, 104:14982-14987.
33. Magri L., Swiss V.A., Jablonska B., Lei L., Pedre X., Walsh M., Zhang W., Gallo V., Canoll P., Casaccia P. E2F1 coregulates cell cycle genes and chromatin components during the transition of oligodendrocyte progenitors from proliferation to differentiation. J Neurosci 2014, 34:1481-1493.
34. Marin-Husstege M., Muggironi M., Liu A., Casaccia-Bonnefil P. Histone deacetylase activity is necessary for oligodendrocyte lineage progression. J Neurosci 2002, 22:10333-10345.
35. Martinato F., Cesaroni M., Amati B., Guccione E. Analysis of Myc-induced histone modifications on target chromatin. PLoS One 2008, 3:e3650.
36. McMahon S.B., Wood M.A., Cole M.D. The essential cofactor TRRAP recruits the histone acetyltransferase hGCN5 to c-Myc. Mol Cell Biol 2000, 20:556-562.
37. Nevins J.R. Toward an understanding of the functional complexity of the E2F and retinoblastoma families. Cell Growth Differ 1998, 9:585-593.
38. Orian J.M., Ahern A.J., Ayers M.M., Levine J.M., Tapp L.D., Reynolds R. Disturbed oligodendrocyte development and recovery from hypomyelination in a c-myc transgenic mouse mutant. J Neurosci Res 2001, 66:46-58.
39. Orian J.M., Mitchell A.W., Marshman W.E., Webb G.C., Ayers M.M., Grail D., Ford J.H., Kaye A.H., Gonzales M.F. Insertional mutagenesis inducing hypomyelination in transgenic mice. J Neurosci Res 1994, 39:604-612.
40. Orian J.M., Slavin A., Ayers M.M., Bernard C.C. Delayed and incomplete myelination in a transgenic mouse mutant with abnormal oligodendrocytes. J Neurosci Res 1997, 50:809-820.
41. Pelengaris S., Khan M., Evan G. C-MYC: more than just a matter of life and death. Nat Rev Cancer 2002, 2:764-776.
42. Ruas M., Peters G. The p16INK4a/CDKN2A tumor suppressor and its relatives. Biochim Biophys Acta 1998, 1378:F115-F177.
43. Shen S., Li J., Casaccia-Bonnefil P. Histone modifications affect timing of oligodendrocyte progenitor differentiation in the developing rat brain. J Cell Biol 2005, 169:577-589.
44. Shen S., Sandoval J., Swiss V.A., Li J., Dupree J., Franklin R.J., Casaccia-Bonnefil P. Age-dependent epigenetic control of differentiation inhibitors is critical for remyelination efficiency. Nat Neurosci 2008, 11:1024-1034.
45. Sherr C.J. The ins and outs of RB: coupling gene expression to the cell cycle clock. Trends Cell Biol 1994, 4:15-18.
46. Sherr C.J. Mammalian G1 cyclins and cell cycle progression. Proc Assoc Am Physicians 1995, 107:181-186.
47. Sherr C.J., Roberts J.M. CDK inhibitors: positive and negative regulators of G1-phase progression. Genes Dev 1999, 13:1501-1512.
48. Sloan E.J., Ayer D.E. Myc, mondo, and metabolism. Genes Cancer 2010, 1:587-596.
49. Song B., Sun G., Herszfeld D., Sylvain A., Campanale N.V., Hirst C.E., Caine S., Parkington H.C., Tonta M.A., Coleman H.A., et al. Neural differentiation of patient specific iPS cells as a novel approach to study the pathophysiology of multiple sclerosis. Stem Cell Res 2012, 8:259-273.
50. Swiss V.A., Nguyen T., Dugas J., Ibrahim A., Barres B., Androulakis I.P., Casaccia P. Identification of a gene regulatory network necessary for the initiation of oligodendrocyte differentiation. PLoS One 2011, 6:e18088.
51. Takahashi K., Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 2006, 126:663-676.
52. Thier M., Worsdorfer P., Lakes Y.B., Gorris R., Herms S., Opitz T., Seiferling D., Quandel T., Hoffmann P., Nothen M.M., et al. Direct conversion of fibroblasts into stably expandable neural stem cells. Cell Stem Cell 2012, 10:473-479.
53. Verhaak R.G., Hoadley K.A., Purdom E., Wang V., Qi Y., Wilkerson M.D., Miller C.R., Ding L., Golub T., Mesirov J.P., et al. Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1. Cancer Cell 2010, 17:98-110.
54. Vervoorts J., Luscher-Firzlaff J.M., Rottmann S., Lilischkis R., Walsemann G., Dohmann K., Austen M., Luscher B. Stimulation of c-MYC transcriptional activity and acetylation by recruitment of the cofactor CBP. EMBO Rep 2003, 4:484-490.
55. Vita M., Henriksson M. The Myc oncoprotein as a therapeutic target for human cancer. Semin Cancer Biol 2006, 16:318-330.
56. Wang J., Wang H., Li Z., Wu Q., Lathia J.D., McLendon R.E., Hjelmeland A.B., Rich J.N. C-Myc is required for maintenance of glioma cancer stem cells. PLoS One 2008, 3:e3769.
57. Weinberg R.A. The retinoblastoma protein and cell cycle control. Cell 1995, 81:323-330.
58. Yuan X., Chittajallu R., Belachew S., Anderson S., McBain C.J., Gallo V. Expression of the green fluorescent protein in the oligodendrocyte lineage: a transgenic mouse for developmental and physiological studies. J Neurosci Res 2002, 70:529-545.